Information
Backnumber
Back Number of 2024
-
NEW1 Apr.
Updated IR Calendar
-
NEW1 Apr.
Updated Corporate Data
-
NEW22 Mar.
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
-
15 Mar.
N-Nitroso Duloxetine Analytical Method Published in ACS Omega
-
28 Feb.
Notice of Disposal of Treasury Shares as Restricted Stock Compensation
-
15 Feb.
Manufacturing and Marketing Approval for Three Ingredients and Eight Items
-
14 Feb.
Notice of Acquisition of Approval for Application for Partial Change of Manufacturing and Marketing Approval for Esomeprazole Capsules concerning the Addition of a Manufacturing Plant
-
13 Feb.
Notice of Revisions of Financial Forecasts
-
13 Feb.
FY2023(3rd quarter) Supplementary Material of Financial Results
-
13 Feb.
Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2023(Based on Japanese GAAP)
-
4 Jan.
Updated IR Calendar